The Assessment of Burden of ColoRectal Cancer (ABCRC)-tool; a validity and reliability study

Britt J.M. Thomassen*, Merel L. Kimman, Anne M.J. Somers, Rudolf W.H.M. Ponds, Jan Willem T. Dekker, Barbara L. van Leiden, Geraldine R. Vink, Jan Willem B. de Groot, Jarno Melenhorst, Kim M.M.W. Reynders, Christel M.J. Gielen, Tom H.A. Weerts, Martijn F. Lutke Holzik, Sander M.J. van Kuijk, Stéphanie O. Breukink, Annerika H.M. Gidding-Slok

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Introduction: Follow-up care after treatment for colorectal cancer (CRC) is increasingly focused on health-related quality of life (HRQoL) and functional outcomes. The Assessment of Burden of ColoRectal Cancer (ABCRC)-tool is developed to measure these outcomes and support patient-oriented care. The tool comprises items assessing burden of disease and lifestyle parameters. It consists of a generic module combined with one of the three CRC specific modules. The objective of this study is to assess the construct validity and reliability of the items of the ABCRC-tool. Methods: Patients who were receiving follow-up care after surgical CRC treatment were invited to complete the ABCRC-tool together with other validated patient-reported outcome measures (PROMs). Construct validity was assessed by testing expected correlations between items of the ABCRC-tool and domains of other PROMs and by examining predefined hypotheses regarding differences in subgroups of patients. Patients completed the ABCRC-tool twice, with 8 days apart, to evaluate its reliability. Results: In total, 177 patients participated (64% male) with a mean age of 67 years (range 33–88). The colon, rectum and stoma module were completed by subsequently 89, 53 and 35 patients. Most items correlated as expected with anticipated domains of the EORTC QLQ-C30 or EORTC QLQ-CR29 (all p-values <0.05). Furthermore, the ABCRC-tool could discriminate between subgroups of patients. The intraclass correlation coefficient (ICC) was good (>0.70) for most items, indicating good reliability. Conclusion: The ABCRC-tool is a valid and reliable instrument that is ready for use in a clinical setting to support personalized follow-up care after CRC treatment.
Original languageEnglish
Article number108032
Number of pages10
JournalEuropean Journal of Surgical Oncology
Volume50
Issue number4
DOIs
Publication statusPublished - 1 Apr 2024

Keywords

  • Colorectal cancer
  • Follow-up
  • Patient reported outcome measure
  • Patient-oriented care

Cite this